Arvinas, Inc. logo

Arvinas, Inc.

Arvinas develops drugs based on targeted protein degradation for treating cancer, pro-inflammatory, autoimmune and rare diseases.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ARVN” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://arvinas.com
Founded2013
Disease Focus
Development Stage
STOCK CODENASDAQ: ARVN
Address
5 Science Park 395 Winchester Ave.,CT,6511
New Haven
United States
Email
Contact Number
+1 203 535 1456

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/arvinas” connections=”true” suffix=””]